137 related articles for article (PubMed ID: 30030187)
21. A type of rat hepatosplenic gamma-delta (gammadalta) T-cell lymphoma developed after injections with hepatocyte growth factor (HGF) oligonucleotides, which was rejected by surviving syngeneic spleen graft.
Nakatsuji T
Leuk Lymphoma; 2003 Jan; 44(1):175-81. PubMed ID: 12691160
[TBL] [Abstract][Full Text] [Related]
22. [Hepatosplenic gammadelta T cell lymphoma and its relationship with Epstein-Barr virus infection].
Gao XN; Tang SQ; Liu Y; Wang JW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1134-7. PubMed ID: 17204179
[TBL] [Abstract][Full Text] [Related]
23. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.
Travert M; Huang Y; de Leval L; Martin-Garcia N; Delfau-Larue MH; Berger F; Bosq J; Brière J; Soulier J; Macintyre E; Marafioti T; de Reyniès A; Gaulard P
Blood; 2012 Jun; 119(24):5795-806. PubMed ID: 22510872
[TBL] [Abstract][Full Text] [Related]
24. Hepatosplenic and other gammadelta T-cell lymphomas.
Vega F; Medeiros LJ; Gaulard P
Am J Clin Pathol; 2007 Jun; 127(6):869-80. PubMed ID: 17509984
[TBL] [Abstract][Full Text] [Related]
25. Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients.
Wu H; Wasik MA; Przybylski G; Finan J; Haynes B; Moore H; Leonard DG; Montone KT; Naji A; Nowell PC; Kamoun M; Tomaszewski JE; Salhany KE
Am J Clin Pathol; 2000 Apr; 113(4):487-96. PubMed ID: 10761449
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS
Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592
[TBL] [Abstract][Full Text] [Related]
27. Pituitary gland involvement by a gamma delta hepatosplenic lymphoma, a mimicker of pituitary adenoma: report of a rare case.
Jain D; Sharma MC; Sarkar C; Suri V; Garg A; Mahapatra AK; Kumar L
J Neurooncol; 2008 Jun; 88(2):237-41. PubMed ID: 18317685
[TBL] [Abstract][Full Text] [Related]
28. Hepatosplenic T-cell lymphoma: A case series.
Ashmore P; Patel M; Vaughan J; Wiggill T; Willem P; van den Berg E; Philip V; Lakha A
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):78-84. PubMed ID: 25450840
[TBL] [Abstract][Full Text] [Related]
29. [A case of hepatosplenic gammadelta T-cell lymphoma associated hemophagocytic syndrome].
Iyama S; Matsunaga T; Sato T; Sato Y; Sagawa T; Murase K; Kida M; Kobune M; Takimoto R; Kato J; Niitsu Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1623-7. PubMed ID: 18799926
[TBL] [Abstract][Full Text] [Related]
30. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature.
Khan WA; Yu L; Eisenbrey AB; Crisan D; al Saadi A; Davis BH; Hankin RC; Mattson JC
Am J Clin Pathol; 2001 Jul; 116(1):41-50. PubMed ID: 11447750
[TBL] [Abstract][Full Text] [Related]
31. Hepatosplenic gamma delta T-cell lymphoma associated with hepatitis B virus infection.
Ozaki S; Ogasahara K; Kosaka M; Inoshita T; Wakatsuki S; Uehara H; Matsumoto T
J Med Invest; 1998 Feb; 44(3-4):215-7. PubMed ID: 9597812
[TBL] [Abstract][Full Text] [Related]
32. Gamma-delta T-cell lymphomas.
Tripodo C; Iannitto E; Florena AM; Pucillo CE; Piccaluga PP; Franco V; Pileri SA
Nat Rev Clin Oncol; 2009 Dec; 6(12):707-17. PubMed ID: 19901919
[TBL] [Abstract][Full Text] [Related]
33. Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.
Gopcsa L; Bányai A; Tamáska J; Karádi A; Matolcsy A; Pálóczi K
Haematologia (Budap); 2002; 32(4):519-27. PubMed ID: 12803128
[TBL] [Abstract][Full Text] [Related]
34. [Dermatomyositis associated with hepatosplenic gamma delta T-cell lymphoma].
Chandesris MO; Crétel-Durand E; Jean R; Rey J; Figarella-Branger D; Sainty D; Durand JM
Rev Med Interne; 2007 Aug; 28(8):552-5. PubMed ID: 17559983
[TBL] [Abstract][Full Text] [Related]
35. Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma.
Charton-Bain MC; Brousset P; Bouabdallah R; Gaulard P; Merlio JP; Dubus P; Rostaing L; de Roux C; Weiller PJ; Hassoun J; Xerri L
Histopathology; 2000 Mar; 36(3):233-9. PubMed ID: 10692026
[TBL] [Abstract][Full Text] [Related]
36. Hepatosplenic T-cell lymphoma in a young immunocompetent man.
Petrova M; Gomes MM; Carda JP; Pereira de Moura J
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033291
[TBL] [Abstract][Full Text] [Related]
37. Hepatosplenic αβ T-cell lymphoma with myelodysplastic syndrome.
Takaku T; Miyazawa K; Sashida G; Shoji N; Shimamoto T; Yamaguchi N; Ito Y; Nakamura S; Mukai K; Ohyashiki K
Int J Hematol; 2005 Aug; 82(2):143-7. PubMed ID: 16146847
[TBL] [Abstract][Full Text] [Related]
38. Primary central nervous system gamma delta cytotoxic T-cell lymphoma.
Mooney KL; Choy W; Woodard J; Xian RR; Deal TM; Kendle RF; Said J; Grody W; Yang I
J Clin Neurosci; 2016 Apr; 26():138-40. PubMed ID: 26804925
[TBL] [Abstract][Full Text] [Related]
39. Rare variety of T-cell lymphoma.
Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
[TBL] [Abstract][Full Text] [Related]
40. Capillaritis as a Skin Manifestation of Hepatosplenic Gamma-Delta T-Cell Lymphoma.
Jakharia-Shah N; Ho B; Lolatgis H; Alarcon L; Abdul-Wahab A
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e733-e735. PubMed ID: 35319511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
